enVVeno Medical Corp Operating Lease Right-of-Use Assets
enVVeno Medical Corp (NVNO) had Operating Lease Right-of-Use Assets of $469.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-07-30
- 2026-06-30: Operating Lease, Right-of-Use Asset $469.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $561.00K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $654.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $740.00K.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $469.00K 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $561.00K 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $654.00K 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $740.00K 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $829.00K 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $925.00K 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $1.01M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $1.09M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $1.18M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $1.26M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.35M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $1.43M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $1.51M 10-Q · filed 2023-07-31 | |
| 2023-03-31 | $1.59M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $1.67M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $1.75M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $1.83M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $1.91M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $1.99M 10-K · filed 2023-03-02 | $1.99M 10-K · filed 2022-03-28 |
| 2021-09-30 | $311.79K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $387.85K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $463.91K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $539.97K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $609.66K 10-Q · filed 2020-11-17 | |
| 2020-06-30 | $681.90K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $760.01K 10-Q · filed 2020-06-08 | |
| 2019-12-31 | $826.40K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $892.78K 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $961.65K 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $1.03M 10-Q · filed 2019-05-09 | |
| 2019-01-02 | $1.10M 10-Q · filed 2019-05-09 | |
| 2019-01-01 | $1.10M 10-Q · filed 2021-11-12 | |
| 2018-12-31 | $1.10M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |